![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Moderna, Inc. Common Stock (MRNA) - Nasdaq
Feb 1, 2025 · Discover real-time Moderna, Inc. Common Stock (MRNA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Moderna, Inc. Common Stock (MRNA) Real-Time Quotes - Nasdaq
Aug 30, 2024 · Get real-time updates on Moderna, Inc. Common Stock (MRNA) stock quotes, trades, and more. Make informed investments with Nasdaq.
Moderna, Inc. Common Stock (MRNA) News Headlines | Nasdaq
Jan 23, 2025 · Stay up-to-date on Moderna, Inc. Common Stock (MRNA) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.
Moderna, Inc. Common Stock (MRNA) Historical Data | Nasdaq
Find the latest historical data for Moderna, Inc. Common Stock (MRNA) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.
Moderna, Inc. Common Stock (MRNA) Pre-Market - Nasdaq
Get the latest updates on Moderna, Inc. Common Stock (MRNA) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Moderna Unusual Options Activity For January 22 - Nasdaq
Jan 22, 2025 · Today, Benzinga's options scanner spotted 13 options trades for Moderna. This isn't normal. The overall sentiment of these big-money traders is split between 46% bullish and 53%, bearish.
Moderna Options Trading: A Deep Dive into Market Sentiment
Feb 3, 2025 · Looking at options history for Moderna (NASDAQ:MRNA) we detected 26 trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish ...
Is Moderna a Bad-News Buy for 2025? - Nasdaq
Jan 16, 2025 · Moderna may reach its product approval and launch goals -- but this will take a few years. Meanwhile, the market could continue to sanction the biotech if sales remain lackluster in 2025.
Moderna Stock At $400. What Are The Risks? - Nasdaq
Aug 18, 2021 · Moderna (NASDAQ: MRNA) stock has rallied by almost 15% over the last week (five trading days), outperforming the S&P 500 which was up by just over 1% over the same period.
Is Moderna Stock a Buy? - Nasdaq
Jan 19, 2025 · Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index.